Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.
2.
6.

Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.

Sher NA, Golben MR, Bond W, Trattler WB, Tauber S, Voirin TG.

J Refract Surg. 2009 Feb;25(2):214-20.

PMID:
19241773
7.

Effect of nepafenac sodium 0.1% on delayed corneal epithelial healing and haze after photorefractive keratectomy: retrospective comparative study.

Jalali S, Yuen LH, Boxer Wachler BS.

J Cataract Refract Surg. 2008 Sep;34(9):1542-5. doi: 10.1016/j.jcrs.2008.04.036.

PMID:
18721717
8.

Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.

Solomon KD, Donnenfeld ED, Raizman M, Sandoval HP, Stern K, VanDenburgh A, Cheetham JK, Schiffman R; Ketorolac Reformulation Study Groups 1 and 2.

J Cataract Refract Surg. 2004 Aug;30(8):1653-60.

PMID:
15313287
9.
11.

Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.

Bucci FA Jr, Waterbury LD.

Adv Ther. 2011 Dec;28(12):1089-95. doi: 10.1007/s12325-011-0080-7. Epub 2011 Nov 18.

PMID:
22105509
12.

Analgesic efficacy and safety of ketorolac after photorefractive keratectomy. Ketorolac Study Group.

Rajpal RK, Cooperman BB.

J Refract Surg. 1999 Nov-Dec;15(6):661-7.

PMID:
10590004
13.
14.

Comparison of analgesic effect of preoperative topical diclofenac and ketorolac on postoperative pain after photorefractive keratectomy.

Hong JP, Nam SM, Im CY, Yoon S, Kim TI, Kim EK, Seo KY.

J Cataract Refract Surg. 2014 Oct;40(10):1689-96. doi: 10.1016/j.jcrs.2014.05.029. Epub 2014 Jun 24.

PMID:
24968759
15.

A prospective randomized trial of topical soluble 0.1% indomethacin versus 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy.

Assouline M, Renard G, Arne JL, David T, Lasmolles C, Malecaze F, Pouliquen YJ.

Ophthalmic Surg Lasers. 1998 May;29(5):365-74.

PMID:
9599360
16.

Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.

Lane SS, Modi SS, Lehmann RP, Holland EJ.

J Cataract Refract Surg. 2007 Jan;33(1):53-8. Erratum in: J Cataract Refract Surg. 2007 Apr;33(4):564.

PMID:
17189793
17.

Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.

Toyos R.

Cornea. 2008 Apr;27(3):384; author reply 384-5. doi: 10.1097/ICO.0b013e31815ca67c. No abstract available.

PMID:
18362678
18.

Comparison of postoperative pain in patients following photorefractive keratectomy versus advanced surface ablation.

Blake CR, Cervantes-Castañeda RA, Macias-Rodríguez Y, Anzoulatous G, Anderson R, Chayet AS.

J Cataract Refract Surg. 2005 Jul;31(7):1314-9.

PMID:
16105600
19.

Efficacy of topical nonsteroidal drops as pain relief after excimer laser photorefractive keratectomy.

Frangouli A, Shah S, Chatterjee A, Morgan PB, Kinsey J.

J Refract Surg. 1998 Apr;14(2 Suppl):S207-8.

PMID:
9571555
20.

Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.

Lindstrom R, Holland E, Lane S, Raizman M, Reilly C.

Cornea. 2008 Apr;27(3):385-6; author reply 386-7. doi: 10.1097/ICO.0b013e31815e7f36. No abstract available.

PMID:
18362679
Items per page

Supplemental Content

Write to the Help Desk